Literature DB >> 11576296

The development of new vaccines against Bacillus anthracis.

L Baillie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11576296     DOI： 10.1046/j.1365-2672.2001.01498.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN： 1364-5072            Impact factor:   3.772


× No keyword cloud information.
  18 in total

1.  Anthrax: a continuing concern in the era of bioterrorism.

Authors:  Stefan Riedel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-07

2.  Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.

Authors:  Margaret G M Stokes; Richard W Titball; Brendan N Neeson; James E Galen; Nicola J Walker; Anthony J Stagg; Dominic C Jenner; Joanne E Thwaite; James P Nataro; Leslie W J Baillie; Helen S Atkins
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

3.  Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening.

Authors:  N Ariel; A Zvi; H Grosfeld; O Gat; Y Inbar; B Velan; S Cohen; A Shafferman
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 4.  Anthrax infection.

Authors:  Daniel A Sweeney; Caitlin W Hicks; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

5.  Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.

Authors:  R Aloni-Grinstein; O Gat; Z Altboum; B Velan; S Cohen; A Shafferman
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.

Authors:  Karen E Brenneman; Mehmet Doganay; Arya Akmal; Stanley Goldman; Darrell R Galloway; Alfred J Mateczun; Alan S Cross; Leslie W Baillie
Journal:  FEMS Immunol Med Microbiol       Date:  2011-04-15

7.  Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop.

Authors:  Jennifer Watson; Vijay Koya; Stephen H Leppla; Henry Daniell
Journal:  Vaccine       Date:  2004-10-22       Impact factor: 3.641

8.  Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens.

Authors:  N Ariel; A Zvi; K S Makarova; T Chitlaru; E Elhanany; B Velan; S Cohen; A M Friedlander; A Shafferman
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide.

Authors:  Li-Chung Hsu; Syed R Ali; Shauna McGillivray; Ping-Hui Tseng; Sanjeev Mariathasan; Eric W Humke; Lars Eckmann; Jonathan J Powell; Victor Nizet; Vishva M Dixit; Michael Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

Review 10.  Chloroplast-derived vaccine antigens and biopharmaceuticals: expression, folding, assembly and functionality.

Authors:  S Chebolu; H Daniell
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.